Business
Nearly 15 Per Cent Rise in Canadian Women Using Fertility Drugs, New Manulife Canada Data Shows
Nearly 15 Per Cent Rise in Canadian Women Using Fertility Drugs, New Manulife Canada Data Shows ...
About this update from Manulife Financial Corporation
[{"type":"text","content":"\n\n\n\n Nearly 15 Per Cent Rise in Canadian Women Using Fertility Drugs, New Manulife Canada Data Shows\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; FONT-SIZE: 8PT; FONT-FAMILY: ARIAL; COLOR: BLACK; MARGIN:0em; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n While more women are seeking assistance, only 1 per cent of Canadian employers offer coverage for fertility clinic treatments\n \n\n\n\n\n TORONTO\n \n\n ,\n \n\n April 23, 2025\n \n\n /CNW/ - To mark Canadian Fertility Awareness Week, Manulife Canada is releasing new data that shows the number of women using fertility drugs is rising. According to claims data\n \n i\n \n , fertility drug usage increased by 14.57 per cent in 2024 compared to the year prior.\n \n\n\n\n\n\n\n\n\n Seeking treatment can be expensive and stressful. One round of in vitro fertilization (IVF) costs approximately\n \n $20,000\n \n\n ii\n \n in\n \n Canada\n \n , and multiple rounds can be required. Employers frequently offer coverage for fertility drugs but not treatments or medical procedures. While one in six couples experience infertility\n \n iii\n \n , fewer than 1 per cent of Canadian employers with a Manulife group benefits plans offer coverage for fertility clinic treatments. About 53 per cent of employers offer coverage for fertility drugs.\n \n\n \"The fertility journey often comes with significant emotional and financial challenges related to the treatments and procedures,\" said\n \n Jennifer Foubert\n \n , Head of Product for Group Benefits at Manulife Canada. \"There is a fertility funding gap in\n \n Canada\n \n . Providing coverage for both drugs and treatment make a tremendous difference for women and their partners in terms of giving them the resources they need to effectively pursue their path to parenthood.\"\n \n\n Currently, there is no national p...